Evidence map›Paper›PMID 42405756›Full record

ArticleMicrobiology spectrum2026

First

Wassel Zekri, Marie-Lou Gaucher, Maud de Lagarde, William Thériault, David Roy, Alexandra Veress, Francis Beaudry, Mohamed Rhouma

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wassel ZekriDépartement de Pathologie et Microbiologie, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada.ORCID 0009-0008-5210-0085
Marie-Lou GaucherDépartement de Pathologie et Microbiologie, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada.
Maud de LagardeDépartement de Pathologie et Microbiologie, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada.
William ThériaultDépartement de Pathologie et Microbiologie, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada.
David RoyDépartement de Pathologie et Microbiologie, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada.
Alexandra VeressDépartement de Pathologie et Microbiologie, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada.
Francis BeaudryDépartement de Biomédecine Vétérinaire, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada.
Mohamed RhoumaDépartement de Pathologie et Microbiologie, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada.ORCID 0000-0002-5629-2474

Funding

Natural Sciences and Engineering Research Council of Canada 2022-04264
6 · The paper itself

Abstract

Although oxytetracycline (OTC) has been widely used in poultry since 1950, comprehensive studies characterizing its degradation products for potential therapeutic applications have not been conducted. The aims of the present study were to evaluate the antibacterial activity of three OTC degradation products (4-α-epi-OTC [4-EOTC], α-apo-OTC, and β-apo-OTC) individually and in combination with OTC, to identify and assess the genetic determinants conferring antimicrobial resistance (AMR) in avian pathogenic

Indexed as

Anti-Bacterial AgentsEscherichia coliEscherichia coli InfectionsOxytetracyclinePoultry DiseasesAnimalsChickensDrug Resistance, BacterialEscherichia coli ProteinsMicrobial Sensitivity TestsPoultryAnti-Bacterial AgentsEscherichia coli ProteinsOxytetracyclineantibacterial activityantimicrobial resistanceAPECdegradation productsgizzard simulationoxytetracycline

Identifiers

PMID42405756
PMCPMC13436374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.